| Overall | TPE | No TPE | p |
---|---|---|---|---|
Site of infection | ||||
 Pneumonia | 26/40 (65%) | 11/23 (47.8%) | 15/17 (88.2%) | 0.017 |
 GU | 2/14 (14.3%) | 0/6 (0%) | 2/8 (25%) |  |
 GI/biliary | 6/12 (50%) | 2/6 (33.3%) | 4/6 (66.7%) |  |
 Skin/soft tissue | 1/5 (20%) | 1/1 (100%) | 0/4 (0%) |  |
 Endocarditis | 2/4 (50%) | 1/3 (33.3%) | 1/1 (100%) |  |
 Primary bacteremia | 5/5 (100%) | 1/1 (100%) | 4/4 (100%) |  |
Organism cultured | ||||
 MRSA | 2/5 (40%) | 1/3 (33.3%) | 1/2 (50%) |  |
 Streptococcus | 3/5 (60%) | 1/2 (50%) | 2/3 (66.7%) |  |
 E. coli | 6/11 (54.5%) | 2/5 (40%) | 4/6 (66.7%) |  |
 Pseudomonas | 2/2 (100%) | 1/1 (100%) | 1/1 (100%) |  |
 Enterococcus | 1/2 (50%) | 0/1 (0%) | 1/1 (100%) |  |
 Enterobacter | 3/8 (37.5%) | 2/3 (66.7%) | 1/5 (20%) |  |
 Klebsiella | 2/6 (33.3%) | 0/4 (0%) | 2/2 (100%) |  |
 Influenza | 2/3 (66.7%) | 0/1 (0%) | 2/2 (100%) |  |
 Serratia | 1/1 (100%) | 1/1 (100%) | n/a |  |
 C. difficile | 1/2 (50%) | n/a | 1/2 (50%) |  |
 Salmonella | 0/1 (0%) | n/a | 0/1 (0%) |  |
 Culture negative | 3/14 (21.4%) | 1/10 (10%) | 2/4 (50%) |  |
 Polymicrobial | 16/20 (80%) | 7/9 (77.8%) | 9/11 (81.8%) |  |